BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND PSA AND Treatment
46 results:

  • 1. brain metastasis in a patient with BRCA2-mutated treatment-related neuroendocrine prostate carcinoma and long-term response to radiotherapy and Olaparib: A case report and literature review.
    Uehara R; Obinata D; Hashimoto S; Nakahara K; Uchida H; Yoshizawa T; Mochida J; Yamaguchi K; Sakaguchi M; Ozawa Y; Mori F; Miura K; Ishige T; Masuda S; Nakayama T; Takahashi S
    Medicine (Baltimore); 2024 Mar; 103(9):e37371. PubMed ID: 38428891
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. treatment modalities and survival outcomes in prostate cancer parenchymal brain metastasis.
    Mahmoud AM; Childs DS; Ahmed ME; Tuba Kendi A; Johnson GB; Orme JJ; Stish BJ; Phillips RM; Park SS; Davis BJ; Andrews JR; Kwon ED
    Prostate; 2024 Feb; 84(3):237-244. PubMed ID: 37899635
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Primary high-grade urothelial carcinoma of prostate with prostatic hyperplasia: a rare case report and review of the literature.
    Liu L; Sun FZ; Zhang PY; Xiao Y; Yue X; Wang DM; Wang Q
    Aging Male; 2023 Dec; 26(1):2252102. PubMed ID: 37642413
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinical Pharmacokinetics and Pharmacodynamics of the Next Generation Androgen Receptor Inhibitor-Darolutamide.
    Podgoršek E; Mehra N; van Oort IM; Somford DM; Boerrigter E; van Erp NP
    Clin Pharmacokinet; 2023 Aug; 62(8):1049-1061. PubMed ID: 37458966
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate cancer.
    Hamdy FC; Donovan JL; Lane JA; Metcalfe C; Davis M; Turner EL; Martin RM; Young GJ; Walsh EI; Bryant RJ; Bollina P; Doble A; Doherty A; Gillatt D; Gnanapragasam V; Hughes O; Kockelbergh R; Kynaston H; Paul A; Paez E; Powell P; Rosario DJ; Rowe E; Mason M; Catto JWF; Peters TJ; Oxley J; Williams NJ; Staffurth J; Neal DE;
    N Engl J Med; 2023 Apr; 388(17):1547-1558. PubMed ID: 36912538
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Construction and validation of web-based nomograms for detecting and prognosticating in prostate adenocarcinoma with bone metastasis.
    Dong Q; Wu X; Gan W; Mok TN; Shen J; Zha Z; Chen J
    Sci Rep; 2022 Nov; 12(1):18623. PubMed ID: 36329203
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Impact of Novel Hormonal Agents (Abiraterone, Enzalutamide) on the Development of Visceral and/or brain Metastases in Patients With Bone-metastatic Castration-resistant Prostate cancer.
    Pobel C; Laurent E; Florence AM; Fromont G; Calais G; Narciso B; Linassier C; Cancel M
    Clin Genitourin Cancer; 2022 Oct; 20(5):495.e1-495.e9. PubMed ID: 35562276
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Induction of IDO1 and Kynurenine by Serine Proteases Subtilisin, Prostate Specific Antigen, CD26 and HtrA: A New Form of Immunosuppression?
    Clanchy FIL; Huang YS; Ogbechi J; Darlington LG; Williams RO; Stone TW
    Front Immunol; 2022; 13():832989. PubMed ID: 35371018
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Mask-Based versus Frame-Based Gamma Knife ICON Radiosurgery in brain Metastases: A Prospective Randomized Trial.
    Régis J; Merly L; Balossier A; Baumstarck K; Hamdi H; Mariani S; Delsanti C; Vincent M; Nigoul JM; Beltaifa Y; Muracciole X
    Stereotact Funct Neurosurg; 2022; 100(2):86-94. PubMed ID: 34933308
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prostate cancer Metastasis to the Pituitary Gland Manifesting as Corticosteroid Withdrawal, and the Impact of the Switch from Prednisone to Dexamethasone on Survival Time.
    Ataikiru O; Abdelsalam M; Avileli M; Hynes T
    Curr Oncol; 2021 Oct; 28(6):4291-4297. PubMed ID: 34898537
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [A Case of Paraneoplastic Opsoclonus and Ataxia Appeared at Progression of Prostate cancer].
    Kurihara K; Fukuhara K; Yanamoto S; Tsugawa J; Tsuboi Y
    Brain Nerve; 2021 Feb; 73(2):179-182. PubMed ID: 33561832
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Evaluation of the effects of androgenic Chinese herbal medicines on androgen receptors and tumor growth in experimental prostate cancer models.
    Zhang ZB; Ip SP; Cho WC; Hu Z; Huang YF; Luo DD; Xian YF; Lin ZX
    J Ethnopharmacol; 2020 Oct; 260():113058. PubMed ID: 32525068
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Mismatch repair deficiency in metastatic prostate cancer: Response to PD-1 blockade and standard therapies.
    Graham LS; Montgomery B; Cheng HH; Yu EY; Nelson PS; Pritchard C; Erickson S; Alva A; Schweizer MT
    PLoS One; 2020; 15(5):e0233260. PubMed ID: 32453797
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Is prospective MRI mapping of the changes in the volume of the prostate gland in prostate cancer patients undergoing 6 months of neo-adjuvant androgen deprivation therapy a step towards a trial to determine those who may benefit from treatment intensification or extended duration?
    Christie DR; Sharpley CF; Mitina N; MacAteer E; Jackson JE; Lunn D
    J Med Imaging Radiat Oncol; 2020 Apr; 64(2):287-292. PubMed ID: 32174016
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [TROUSSEAU'S SYNDROME ACCOMPANIED BY ADVANCED PROSTATE cancer THAT DEVELOPED ISCHEMIC STROKE; A CASE REPORT].
    Kohada Y; Takemoto K; Goriki A; Kajiwara M
    Nihon Hinyokika Gakkai Zasshi; 2019; 110(1):28-31. PubMed ID: 31956215
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Mammosomatotroph and mixed somatotroph-lactotroph adenoma in acromegaly: a retrospective study with long-term follow-up.
    Lv L; Jiang Y; Yin S; Hu Y; Chen C; Ma W; Jiang S; Zhou P
    Endocrine; 2019 Nov; 66(2):310-318. PubMed ID: 31368083
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Robot-Assisted Laparoscopic Prostatectomy for Patient with Hereditary Hemorrhagic Telangiectasia: A Case Report].
    Fukui S; Iemura Y; Matsumura Y; Kagebayashi Y; Samma S
    Hinyokika Kiyo; 2018 Dec; 64(12):505-508. PubMed ID: 30831667
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Cost-effectiveness of preoperative motor mapping with navigated transcranial magnetic brain stimulation in patients with high-grade glioma.
    Butenschön VM; Ille S; Sollmann N; Meyer B; Krieg SM
    Neurosurg Focus; 2018 Jun; 44(6):E18. PubMed ID: 29852777
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Changes in cerebral metabolic activity in men undergoing androgen deprivation therapy for non-metastatic prostate cancer.
    Cherrier MM; Cross DJ; Higano CS; Minoshima S
    Prostate Cancer Prostatic Dis; 2018 Sep; 21(3):394-402. PubMed ID: 29700388
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Metastatic non-muscle invasive bladder cancer with meningeal carcinomatosis: case report of an unexpected response.
    Teyssonneau D; Daste A; Dousset V; Hoepffner JL; Ravaud A; Gross-Goupil M
    BMC Cancer; 2017 May; 17(1):323. PubMed ID: 28494780
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.